Accelerate Diagnostics Stock Price (NASDAQ:AXDX)

Add to My Stocks
$23 $0.35 (1.5%) AXDX stock closing price Sep 21, 2017 (Closing)
Prev Close* : $23.35
Market Cap:
$1.29B
Day Low: $22.9
52 Week Low: $19.20
Open: $23.15
Volume: 98438
Day High: $23.45
52 Week High: $30.45
Dividend:
N/A

Latest Stock Market News

Latest Articles

Accelerate Diagnostics News - From Partners

AXDX Stockcharts

View AXDX PE ratio, PS ratio stocks charts and compare with peers.
AXDX Chart
Note: Compare Accelerate Diagnostics stock price history with the index and industry peers.

Accelerate Diagnostics Valuation

PS ratio (
price to sales ratio
)
977.87
PB ratio (
price to book ratio
)
12.7

Accelerate Diagnostics Financial Ratios

Asset Turnover
0.03
Receivables Turnover
4.01

AXDX Industry Peers

Company Price Change (%)
Integer Holdings (ITGR)48.30.45 (0.92%)
Galukos (GKOS)32.20.55 (1.68%)
Wafergen Biosystems (WGBS)6.90 (0%)
Bruker Corp (BRKR)29.420.32 (1.08%)
Thermo Fisher Scientific (TMO)187.910.69 (0.37%)
Becton Dickinson (BDX)191.562.44 (1.26%)
Pacific Biosciences Of California (PACB)5.270.12 (2.23%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Opko Health (OPK)6.480.15 (2.37%)
Cognetix Medical (CGNT)2.620.06 (2.34%)
RTI Surgical (RTIX)4.650.1 (2.2%)
ABIOMED (ABMD)159.792.37 (1.51%)
Luminex (LMNX)19.680.18 (0.92%)
Natus Medical (BABY)34.550.25 (0.73%)
LivaNova (LIVN)69.020.39 (0.57%)
Top gainers from Medical Instruments industry
* As of Sep 22, 2017
CompanyPriceChange (%)
Neovasc (NVCN)1.640.09 (5.2%)
Fluidigm (FLDM)4.930.2 (3.9%)
Accuray (ARAY)4.450.15 (3.26%)
Cantel Medical (CMD)85.632.65 (3%)
Mesa Labs (MLAB)145.954.01 (2.67%)
Veracyte (VCYT)8.30.22 (2.58%)
Pacific Biosciences Of California (PACB)5.270.12 (2.23%)
Top losers from Medical Instruments industry
* As of Sep 22, 2017

Accelerate Diagnostics Inc Stock News - Partner Headlines

Accelerate Diagnostics Financial Statements

income statement20162015201420132012
Net Sales or Revenues0.24M0.14M0.12M0.04M-
Net Income-66.37M-45.49M-30.93M-15.28M-
Total Operating Expense66.74M45.69M31.63M15.35M-
View Accelerate Diagnostics income statement
balance sheet20162015201420132012
Total Assets82.85M139.32M69.8M43.43M13.31M
Total Liabilities5.03M6.3M3.81M1.91M1.24M
Shareholders Equity77.81M133.01M65.99M41.51M12.06M
View Accelerate Diagnostics balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities1.54M-1.36M1.25M-
Net Cash from (used by) Operating Activities-53.4M-35.12M-18.78M-9.74M-
Increase (Decrease) in Prop Plant And Equipment-2.4M-3.65M-1.93M-1.15M-
View Accelerate Diagnostics cash flow statement

Accelerate Diagnostics Stock Message Board

Accelerate Diagnostics stock price ended the last trading day at 23. Accelerate Diagnostics market capitalization is 1.29B and it represents the total market value of AXDX stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Accelerate Diagnostics stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Accelerate Diagnostics is worth a lot, it will most likely be reflected in an inflated Accelerate Diagnostics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. The volume number in Accelerate Diagnostics stock quote data shows the number of shares traded. For Ex: 98438 Accelerate Diagnostics shares were traded as of last trading day, as seen from Accelerate Diagnostics stock chart. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Accelerate Diagnostics stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.